
We are seeking an experienced and motivated Health & Safety at our life sciences facility in Alderley Park.
In this standalone site role, as the primary EHS advisor for the site, you will translate the global EHS strategy and will lead the development and continuous improvement of EHS systems at Alderley Park.
This position is ideal for someone with existing EHS experience ideally in life-science organisation good knowledge of COSHH and industrial hygiene, to take next step in their career combining independence, professional development, and influence with the backing of a collaborative global EHS community.
Role: EHS Senior Specialist
Hours: Full time, 37.5 hours per week
Location: Alderley Park, Macclesfield, SK10 4TG.
Our Company
Cyprotex is part of the Evotec Group, a global leader in research. With state-of-the-art facilities and technical expertise, we provide innovative and bespoke assurance tailored to each of our client’s needs. Cyprotex specialises in in vitro and in silico ADME-Tox services.
Our Alderley Park site is set in the heart of Cheshire surrounded by a stunning 400-acre estate, open green spaces, and sweeping viewpoints, all within easy reach of Merseyside and Greater Manchester, Staffordshire, and Shropshire. Easy access to public transport.
Key Responsibilities:
Qualifications & Experience
Essential
Desirable
We offer a competitive salary and benefits package
Onsite Facilities
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.

Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients.
Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing.
We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI.
We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.